myPHteam

Starting a new medication is a big step, and it's completely normal to have questions about what's ahead. Winrevair (sotatercept) is a first-in-class treatment for pulmonary arterial hypertension (PAH), meaning it works differently from other PAH medications — it targets a pathway that helps rebalance cell growth in the Show Full Answer

Starting a new medication is a big step, and it's completely normal to have questions about what's ahead. Winrevair (sotatercept) is a first-in-class treatment for pulmonary arterial hypertension (PAH), meaning it works differently from other PAH medications — it targets a pathway that helps rebalance cell growth in the pulmonary arteries.

It's given as a subcutaneous (under the skin) injection, typically once every three weeks by a healthcare provider. Here are some common side effects to be aware of:

- Headaches
- Low blood pressure (hypotension) — you may feel lightheaded or dizzy
- Swelling in the arms and legs (edema) from fluid buildup
- Anemia (low red blood cell count)
- Nosebleeds

These side effects were reported in at least 10% of patients in clinical trials and were at least 5% more common than in those not taking the medication. It's really important to report any new or worsening symptoms to your care team promptly. Keeping a journal of how you feel after each dose can be a helpful way to track changes and have informed conversations with your doctor.

Wishing you all the best on Tuesday — this is a meaningful step in managing your PAH! 💙

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

4 PAH Pathways Explained: How Treatments Target Them

4 Advances in Pulmonary Arterial Hypertension Treatment